{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:52:06Z","timestamp":1773168726259,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ajo.2006.04.052","type":"journal-article","created":{"date-parts":[[2006,8,29]],"date-time":"2006-08-29T07:41:20Z","timestamp":1156837280000},"page":"469-474.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy of Apraclonidine 0.5% in the Diagnosis of Horner Syndrome in Pediatric Patients Under Low or High Illumination"],"prefix":"10.1016","volume":"142","author":[{"given":"Po-Liang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsien","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiann-Torng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Win-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2006.04.052_bib1","series-title":"Clinical neuro-ophthalmology","first-page":"514","article-title":"Disorders of papillary function, accommodation, and lacrimation","author":"Thompson","year":"1969"},{"key":"10.1016\/j.ajo.2006.04.052_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bjo.59.12.731","article-title":"Pupillary \u201cdilation lag\u201d in Horner syndrome","volume":"59","author":"Pilley","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1091-8531(98)90008-8","article-title":"Pediatric Horner syndrome","volume":"2","author":"Jeffery","year":"1998","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2006.04.052_bib4","first-page":"951","article-title":"Ocular effects of apraclonidine in Horner syndrome","volume":"118","author":"Morales","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib5","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archopht.121.8.1201","article-title":"The utility of 0.5% apraclonidine in the diagnosis of Horner syndrome","volume":"121","author":"Brown","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib6","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archopht.122.2.276","article-title":"The role of apraclonidine in the diagnosis of Horner syndrome in pediatric patients","volume":"122","author":"Bacal","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib7","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bjo.2005.074492","article-title":"The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis","volume":"89","author":"Koc","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib8","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archopht.1990.01070050082036","article-title":"Critical evaluation of the cocaine test in the diagnosis of Horner syndrome","volume":"108","author":"Kardon","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2460\/ajvr.1996.57.01.83","article-title":"Effect of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cat","volume":"57","author":"Miller","year":"1996","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.ajo.2006.04.052_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3109\/02713689209033494","article-title":"Pharmacological evidence for heterogeneity of ocular \u03b12 adrenoceptors","volume":"11","author":"Crosson","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2006.04.052_bib11","first-page":"83","article-title":"Are we ready to replace cocaine with apraclonidine in the pharmacologic diagnosis of Horner syndrome?","volume":"25","author":"Kardon","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archopht.1990.01070030100037","article-title":"Normal pupil size and anisocoria in newborn infants","volume":"108","author":"Roatry","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib13","first-page":"1205","article-title":"Short-term effects of unilateral 1% apraclonidine therapy","volume":"105","author":"Robin","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00041327-200303000-00010","article-title":"Clinical applications of pupillography","volume":"23","author":"Wilhelm","year":"2003","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib15","first-page":"149","article-title":"Disorders of the pupil","volume":"14","author":"Kawasaki","year":"2001","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.ajo.2006.04.052_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jop.1995.11.267","article-title":"Evaluation of adverse reaction of aponidine hydrochloride ophthalmic solution","volume":"11","author":"Lin","year":"1995","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2006.04.052_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00917987","article-title":"Apraclonidine and clonidine","volume":"16","author":"Yukesl","year":"1992","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib18","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archopht.1996.01100140146006","article-title":"A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol","volume":"114","author":"Stewart","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib19","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/archopht.1987.01060090063028","article-title":"The safety and efficacy of topical ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers","volume":"105","author":"Abrams","year":"1987","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9394(99)00083-5","article-title":"Apparent central nervous system depression in infants after the use of topical brimonidine","volume":"128","author":"Carlsen","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2006.04.052_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mpa.2001.117571","article-title":"Safety and efficacy of brimonidine in children with glaucoma","volume":"5","author":"Enyedi","year":"2001","journal-title":"J AAPOS"},{"key":"10.1016\/j.ajo.2006.04.052_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archopht.1995.01100030041019","article-title":"The efficacy of apraclonidine as an adjunct to timolol therapy","volume":"113","author":"Stewart","year":"1995","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406005496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939406005496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:52:34Z","timestamp":1757595154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939406005496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0002939406005496"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2006.04.052","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Apraclonidine 0.5% in the Diagnosis of Horner Syndrome in Pediatric Patients Under Low or High Illumination","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2006.04.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}